I have had countless patients return with positive comments regarding their improvement with Tri-Luma,” added Amit G. The clinical studies performed with TriLuma, which led to its approval, provide the evidence dermatologists need to use this product confidently. “Tri-Luma is the most effective branded prescription product I have used for my patients with melasma since I began practicing dermatology more than 20 years ago. Callender, MD, Medical Director, Callender Dermatology and Cosmetic Center in Glenn Dale, MD.
I am really excited that it is back,” said Valerie D. In my practice, the most effective therapy that I have used has been TriLuma. In fact, I have had many patients who have lost their job or have avoided social situations because of the way they look and feel about their skin. It is emotionally and psychologically devastating to patients and has a negative impact on their quality of life. “One of the most difficult hyperpigmentation disorders to treat is melasma. “Galderma is more than ever committed to delivering innovative medical solutions to meet the dermatological needs of patients throughout their lifetime while serving healthcare professionals.” Our greatest satisfaction comes from the realization that TriLuma can actually help people and positively change their lives,” explains François Fournier, President of Galderma’s US and Canadian Operations. At Galderma we engage with doctors to develop an empathetic understanding of melasma and the impact it has on patients. “Tri-Luma is the only FDA-approved product containing hydroquinone 4% to treat melasma patients safely and effectively. People of Latin, Asian, Indian, Middle Eastern, Mediterranean and North African descent, as well as people with a family history of melasma, are more likely to suffer from the condition.
Because melasma is so common during pregnancy, it is sometimes referred to as “the mask of pregnancy.” Sun exposure is also a major melasma trigger because ultraviolet (UV) light from the sun increases melanin production. There are many factors that are associated with melasma including the use of birth control pills, hormone therapy, cosmetics and anti-seizure medications. Melasma usually appears on the face, although it can also develop on the forearms and neck.
TRILUMA CREAM SKIN
Melasma is a common skin condition that causes the appearance of brown to gray-brown patches of skin due to the body producing too much melanin, a natural substance that gives color to skin, hair and eyes. Tri-Luma® Cream contains a clinically-proven formula which combines three active ingredients: fluocinolone acetonide 0.01%, a mild corticosteroid that reduces inflammation hydroquinone 4%, a depigmenting agent that interrupts the formation and synthesis of melanin to help lighten the skin and tretinoin 0.05%, which works to increase the skin cell turnover rate to exfoliate skin. Clinically Proven Treatment Can Help More than 7 Million Suffering from Melasma in the U.S.įort Worth, Texas (February 12, 2013) - Galderma Laboratories, L.P.’s Tri-Luma® (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) Cream, the only FDA-approved triple combination topical product indicated for the short-term (up to 8 weeks) treatment of moderate to severe melasma of the face, is now available to the more than 7 million people who suffer from this chronic skin condition.
0 kommentar(er)
